Navigation Links
Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
Date:2/4/2008

BEIJING and CLAREMONT, Calif., Feb. 4 /Xinhua-PRNewswire-FirstCall/ -- (OTC Bulletin Board: KWBT) Kiwa Bio-Tech Products Group Corporation's CEO and Board Chairman, Mr. Wei Li, met to discuss cooperative ventures with members of the Canadian Agricultural Ministry and Natunola Health, Inc. of Ottawa (Toronto Venture Exchange Symbol: SXS).

Among the participants in the meetings with Mr. Li was Dr. Jianqiang Zhou who is the Chief Officer of Scientific Relations China, International Science Cooperation Bureau of Canadian Agricultural Ministry. During the session, Dr. Zhou introduced three main areas for cooperative development:
-- advanced technology for growing oats

-- a breeding program for promising potatoes,

-- soil nutrient measurement and development of formulas and

fertilization technology transferring experience from research being

conducted for Kiwa at China Agricultural University Mr. Zhou looks to Kiwa to bring a commercial operation focus for the above three projects in order to effectively utilize available governmental capital and support. Based on the successful government directed communication between these two countries, project implementation needs experienced commercial business companies with demonstrated strengths to join together.

Mr. Li also met with Dr. Nam Fong Han, President and CEO, of Canadian listed company, Natunola Health, Inc. (Toronto Venture Exchange Symbol: SXS) in Ottawa, to discuss working together through Canada-China Agri-Technology cooperation arrangements including possible commercial cooperation between Natunola and Kiwa in the near future. Natunola Health Inc. specializes in developing products derived from natural sources primarily for human health, personal care and animal nutritional market. Natunola Health Inc. helps the commercialization of one of Agriculture and Agri-Food Canada (AAFC) patented technologies, omega-3 flaxseed dehulling technology, and has an excellent working relationship with AAFC.

Mr. Wei Li, Chairman of the Board and CEO of the Company, stated, "Through these meetings, Kiwa has established good relations with Canadian government agencies, technology development organizations and commercial operations with the Canadian agricultural industry. This lays the groundwork for future discussions."

About Natunola Health Inc.

The Canadian company based in Ottawa, Ontario is becoming a leading supplier of botanical ingredients to the cosmetic industry as well as shelled flaxseed to the food industry.

Thanks to its patented technologies, in particular its Vegetable Gel Technology, Natunola is able to offer health conscious consumers a unique natural alternative to petroleum-based ingredients. Natunola offers its customers vegetable gels based on canola, sunflower, castor and rice bran oils, as well as customized ingredients.

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( http://www.sec.gov ) or visit the Company's website at http://www.kiwabiotech.com .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

Tel: +1-626-715-5855

Email: kiwabiotech@gmail.com

Robert Schechter

Equity Communications

Tel: +1-212-499-6809

Email: ir4kiwa@hotmail.com


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007
2. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
3. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
4. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
5. Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million
6. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
7. Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month
8. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
9. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):